Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Seminoma
- PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
- De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
- A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
- Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
- Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
- Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
- Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
- Carboplatin AUC-10 With Early PET Scanning in Metastatic Seminoma
- Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
- Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
- Therapy De-escalation in Seminoma Stage IIA/B
- ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors
- Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
- Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
- Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
- Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
- Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma
- Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer